Class information for:
Level 1: IDARUBICIN//IDARUBICINOL//MODIFIED ANTIBIOT

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
8111 1291 26.2 55%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
5 4 CHEMISTRY, ORGANIC//CHEMISTRY, INORGANIC & NUCLEAR//CHEMISTRY, MULTIDISCIPLINARY 1745167
346 3       CARDIOTOXICITY//ANTHRACYCLINES//CAMPTOTHECIN 36072
2252 2             ANGUCYCLINE//IDARUBICIN//ANGUCYCLINONE 4694
8111 1                   IDARUBICIN//IDARUBICINOL//MODIFIED ANTIBIOT 1291

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 IDARUBICIN authKW 339740 5% 21% 70
2 IDARUBICINOL authKW 318659 1% 84% 16
3 MODIFIED ANTIBIOT address 305158 2% 65% 20
4 PIRARUBICIN authKW 165514 2% 25% 28
5 DOXORUBICINOL authKW 158935 1% 40% 17
6 EPIRUBICIN authKW 117467 5% 7% 68
7 HOSP PHARM YAMASHIMA KU address 94603 0% 100% 4
8 DAUNORUBICIN authKW 91894 4% 8% 47
9 DOXORUBICIN authKW 86306 12% 2% 151
10 ORAL IDARUBICIN authKW 84464 0% 71% 5

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 12957 52% 0% 667
2 Pharmacology & Pharmacy 5111 37% 0% 484
3 Chemistry, Analytical 1652 16% 0% 212
4 Hematology 363 6% 0% 76
5 Biochemical Research Methods 345 6% 0% 82
6 Toxicology 33 2% 0% 30
7 Chemistry, Medicinal 31 2% 0% 29
8 CYTOLOGY & HISTOLOGY 23 0% 0% 3
9 Medical Laboratory Technology 21 1% 0% 12
10 Medicine, Research & Experimental 7 2% 0% 28

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 MODIFIED ANTIBIOT 305158 2% 65% 20
2 HOSP PHARM YAMASHIMA KU 94603 0% 100% 4
3 5 MISASAGINAKAUCHI CHO 47302 0% 100% 2
4 DAR ES SALAAM UNIV EDUC 31533 0% 67% 2
5 SURG UNIT SEMEIOT CHIRURG 31533 0% 67% 2
6 ABT IMMUNREGULAT 23651 0% 100% 1
7 CARDIOL PEDIAT ONCOL HEMATOL 23651 0% 100% 1
8 CLIN TRIALS BMBF 01KN1105 23651 0% 100% 1
9 CNRSUNITE MIXTE 176IC 23651 0% 100% 1
10 CU CANC PHARMACOL CORE 23651 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CANCER CHEMOTHERAPY AND PHARMACOLOGY 64117 11% 2% 141
2 CANCER TREATMENT REPORTS 28968 4% 2% 52
3 EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY 18091 3% 2% 38
4 INVESTIGATIONAL NEW DRUGS 17085 3% 2% 43
5 MEDICAL ONCOLOGY AND TUMOR PHARMACOTHERAPY 4671 1% 2% 8
6 TUMORI 3127 2% 1% 25
7 DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH 2862 1% 1% 15
8 JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS 2030 2% 0% 31
9 JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES 1728 2% 0% 30
10 JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS 1663 1% 0% 16

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 IDARUBICIN 339740 5% 21% 70 Search IDARUBICIN Search IDARUBICIN
2 IDARUBICINOL 318659 1% 84% 16 Search IDARUBICINOL Search IDARUBICINOL
3 PIRARUBICIN 165514 2% 25% 28 Search PIRARUBICIN Search PIRARUBICIN
4 DOXORUBICINOL 158935 1% 40% 17 Search DOXORUBICINOL Search DOXORUBICINOL
5 EPIRUBICIN 117467 5% 7% 68 Search EPIRUBICIN Search EPIRUBICIN
6 DAUNORUBICIN 91894 4% 8% 47 Search DAUNORUBICIN Search DAUNORUBICIN
7 DOXORUBICIN 86306 12% 2% 151 Search DOXORUBICIN Search DOXORUBICIN
8 ORAL IDARUBICIN 84464 0% 71% 5 Search ORAL+IDARUBICIN Search ORAL+IDARUBICIN
9 THP ADRIAMYCIN 75681 0% 80% 4 Search THP+ADRIAMYCIN Search THP+ADRIAMYCIN
10 EPIRUBICINOL 70953 0% 100% 3 Search EPIRUBICINOL Search EPIRUBICINOL

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 MAUDENS, KE , STOVE, CP , LAMBERT, WE , (2011) QUANTITATIVE LIQUID CHROMATOGRAPHIC ANALYSIS OF ANTHRACYCLINES IN BIOLOGICAL FLUIDS.JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. VOL. 879. ISSUE 25. P. 2471 -2486 75 79% 5
2 HOLLINGSHEAD, LM , FAULDS, D , (1991) IDARUBICIN - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN THE CHEMOTHERAPY OF CANCER.DRUGS. VOL. 42. ISSUE 4. P. 690-719 98 75% 72
3 FIELDS, SM , KOELLER, JM , (1991) IDARUBICIN - A 2ND-GENERATION ANTHRACYCLINE.DICP-THE ANNALS OF PHARMACOTHERAPY. VOL. 25. ISSUE 5. P. 505-517 81 84% 13
4 GOEBEL, M , (1993) ORAL IDARUBICIN - AN ANTHRACYCLINE DERIVATIVE WITH UNIQUE PROPERTIES.ANNALS OF HEMATOLOGY. VOL. 66. ISSUE 1. P. 33-43 68 83% 29
5 BUCKLEY, MM , LAMB, HM , (1997) ORAL IDARUBICIN - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL EFFICACY IN THE TREATMENT OF HAEMATOLOGICAL MALIGNANCIES AND ADVANCED BREAST CANCER.DRUGS & AGING. VOL. 11. ISSUE 1. P. 61-86 66 71% 16
6 CRIVELLARI, D , LOMBARDI, D , SPAZZAPAN, S , VERONESI, A , TOFFOLI, G , (2004) NEW ORAL DRUGS IN OLDER PATIENTS: A REVIEW OF IDARUBICIN IN ELDERLY PATIENTS.CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. VOL. 49. ISSUE 2. P. 153-163 48 72% 15
7 ROBERT, J , (1994) CLINICAL PHARMACOKINETICS OF EPIRUBICIN.CLINICAL PHARMACOKINETICS. VOL. 26. ISSUE 6. P. 428-438 46 88% 37
8 ROBERT, J , GIANNI, L , (1993) PHARMACOKINETICS AND METABOLISM OF ANTHRACYCLINES.CANCER SURVEYS. VOL. 17. ISSUE . P. 219-252 71 46% 91
9 BEIJNEN, JH , UNDERBERG, WJM , (1988) HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC BIOANALYSIS OF ANTHRACYCLINE CYTOSTATIC DRUGS.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. VOL. 6. ISSUE 6-8. P. 677-685 53 88% 11
10 TAEI, M , HASANPOUR, F , SALAVATI, H , MOHAMMADIAN, S , (2016) FAST AND SENSITIVE DETERMINATION OF DOXORUBICIN USING MULTI-WALLED CARBON NANOTUBES AS A SENSOR AND COFE2O4 MAGNETIC NANOPARTICLES AS A MEDIATOR.MICROCHIMICA ACTA. VOL. 183. ISSUE 1. P. 49 -56 18 82% 3

Classes with closest relation at Level 1


Rank Class id link
1 34581 MENOGARIL//DNA UNWINDING ACTIVITY//N O O TRIANGULAR PHARMACOPHORE
2 15583 METHOXYMORPHOLINO DOXORUBICIN//AD 198//MORPHOLINYLANTHRACYCLINES
3 1652 DOXORUBICIN//CARDIOTOXICITY//DEXRAZOXANE
4 10232 MITOXANTRONE//PIXANTRONE//PIROXANTRONE
5 10766 ETOPOSIDE//ETOPOSIDE PHOSPHATE//ORAL ETOPOSIDE
6 3806 CYTOSINE ARABINOSIDE//ARA CTP//CYTARABINE
7 37538 HETEROCYCLIC TRIOXIRANES//TEROXIRONE//HUMAN NON SMALL CELL LUNG CANCER CELLS
8 22766 ANTHRAQUINONE DISULPHONATES//NAA UNIT//SOLVENT POLARITY EFFECT
9 4400 CARDIOTOXICITY//ANTHRACYCLINES//CARDIO ONCOLOGY
10 216 MULTIDRUG RESISTANCE//P GLYCOPROTEIN//PSC 833

Go to start page